InvestorsHub Logo
Followers 0
Posts 111
Boards Moderated 0
Alias Born 02/09/2017

Re: None

Thursday, 05/18/2017 11:46:06 AM

Thursday, May 18, 2017 11:46:06 AM

Post# of 30352
Seems like you guys approved the increase in authorized shares. From 15,000,000 to 30,000,000. That and every proposal that was voted on. Cannot say I am surprised. This was management's plan from the moment they decided to sell Vitaros ex-U.S.. It was to dilute and continue diluting the existing shareholders in order to keep receiving their overpaid salary in addition to share options and bonuses.

Where is the increase to shareholder value? The only investors benefiting for the last 6 years are investors that sold this company short.

When I first bought my very first shares in Nexmed it was trading at .11. Then came a 1/15 reverse split in 2010 and then another 1/10 reverse split in 2016. That means that in comparison the actual share price is .006. For anybody that happened to stay that long and remain a faithful long term shareholder, this was their reward! How is this for current and past management's creation of shareholder value? And for them to tout this on their website is just a slap on the face for anybody that believed in them.

How does $1,000 U.S. invested in Nexmed in 2009 being worth only $60 U.S. in Apricus shares today sound? I guess you can consider yourself lucky that Vitaros was ever approved ( in Canada and the Europe ) or else it wouldn't even be worth that.



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News